Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02050230Phase 4Terminated
Phase 4, randomised, triple-blind trial of red blood cells in anemia, sponsored by Medical University of Vienna. Primary endpoints: Pulmonary Arterial Pressure and Pulmonary Vascular Resistance. Started Jan 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02050230.